vimarsana.com

உம் பிரிவு ஆஃப் உயிரியல் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UM Student Earns Top Score on MCAT Exam

UM Student Earns Top Score on MCAT Exam University of Montana 19 March 2021 UM student Devin Hunt earned a top score on the Medical College Admission Test. The biology and microbiology major was awarded a yearlong fellowship next year with the National Institute of Allergy and Infectious Diseases. MISSOULA – Devin Hunt said he technically cracked the first book to prepare for the Medical College Admission Test, or MCAT, in August. But the truth, Hunt said, is that spending four years at the University of Montana deeply embedded in microbiology and biology classes, working in research labs and studying under the tutelage of faculty mentors, meant he had really been preparing for years.

Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosis

Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosis University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis. The research was published Feb. 23 in the journal Cell Reports. Cystic fibrosis is a life-threatening disease that causes persistent lung infections and limits a person s ability to breathe over time. A common strain of bacteria, Pseudomonas aeruginosa, often thrives in the lungs of people with cystic fibrosis, as well as in wounds from burns or diabetic ulcers. Once a P. aeruginosa infection is established, it can be incredibly difficult to cure, despite repeated courses of antibiotics.

Research reveals how bacteria defeat drugs that fight cystic fibrosis

 E-Mail IMAGE: UM researcher Laura Jennings helped discover a strategy used by bacteria to defeat antibiotics and other drugs used to fight infections caused by cystic fibrosis. view more  Credit: UM photo MISSOULA - University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis. The research was published Feb. 23 in the journal Cell Reports. Cystic fibrosis is a life-threatening disease that causes persistent lung infections and limits a person s ability to breathe over time. A common strain of bacteria, Pseudomonas aeruginosa, often thrives in the lungs of people with cystic fibrosis, as well as in wounds from burns or diabetic ulcers. Once a P. aeruginosa infection is established, it can be incredibly difficult to cure, despite repeated courses of antibiotics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.